Back

nSIGHT™: A Data Discovery Platform for Visualization, Integration and Retrospective Analysis of Multimodal Clinical Research Data

Zia, M. K.; Plessinger, B.; Eng, K. H.; Flierl, A.; Wilbert, M.; Jans, K.; Whalen, P.; Mullin, S.; Ohm, J.; Singh, A. K.; Farrugia, M.; Morrison, C.; Darlak, C. J.; Seshadri, M.

2026-03-11 oncology
10.64898/2026.03.10.26347202 medRxiv
Show abstract

The lack of interoperability among clinical and research data systems poses a significant barrier to cancer researchers interested in evaluating novel mechanistic hypotheses or translating innovative treatment strategies from the laboratory to the clinic. To address this gap in knowledge, we developed an innovative, web-based, data discovery, visualization and analysis tool (nSight) that allows researchers to quickly and easily query clinical/research data and construct de-identified cancer cohorts. Guiding principles for development of the tool were focused on ease of use, intuitiveness, self-service, and presentation of structured but de-identified data to the end user. nSight provides users with information on patient demographics, disease histology, diagnostic procedures and therapeutic interventions, timeline of disease progression/recurrence, along with available molecular profiling/sequencing data and indicators of participation in epidemiologic or lifestyle studies for specific cancer patient cohorts. The platform also allows users to obtain summary statistics based on demographic, histologic and clinical factors as well as perform basic survival analysis using Kaplan-Meier curves between specific patient cohorts. nSight is an intuitive, user-friendly tool that enables visualization, integration and analysis of multimodal clinical and research data without placing high technical demands or time constraints on researchers. The platform is designed for research feasibility assessment, cohort development, and retrospective data discovery, which in turn should help investigators identify potential study populations and explore novel hypotheses.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
JCO Clinical Cancer Informatics
18 papers in training set
Top 0.1%
22.3%
2
PLOS ONE
4510 papers in training set
Top 26%
6.7%
3
npj Digital Medicine
97 papers in training set
Top 0.8%
6.2%
4
PLOS Computational Biology
1633 papers in training set
Top 9%
3.9%
5
Nature Communications
4913 papers in training set
Top 40%
3.5%
6
Scientific Reports
3102 papers in training set
Top 38%
3.5%
7
Database
51 papers in training set
Top 0.2%
2.8%
8
Briefings in Bioinformatics
326 papers in training set
Top 3%
2.6%
50% of probability mass above
9
European Journal of Cancer
10 papers in training set
Top 0.1%
2.3%
10
iScience
1063 papers in training set
Top 10%
2.1%
11
Frontiers in Oncology
95 papers in training set
Top 2%
2.1%
12
Frontiers in Bioinformatics
45 papers in training set
Top 0.1%
2.1%
13
Bioinformatics
1061 papers in training set
Top 7%
1.9%
14
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.3%
1.7%
15
NAR Genomics and Bioinformatics
214 papers in training set
Top 2%
1.7%
16
Cancer Research
116 papers in training set
Top 2%
1.7%
17
BMC Bioinformatics
383 papers in training set
Top 5%
1.6%
18
Journal of Translational Medicine
46 papers in training set
Top 1.0%
1.6%
19
Artificial Intelligence in Medicine
15 papers in training set
Top 0.4%
1.3%
20
Patterns
70 papers in training set
Top 1%
1.3%
21
PeerJ
261 papers in training set
Top 10%
1.2%
22
Metabolites
50 papers in training set
Top 0.9%
0.9%
23
eLife
5422 papers in training set
Top 54%
0.9%
24
Nucleic Acids Research
1128 papers in training set
Top 17%
0.8%
25
Clinical Cancer Research
58 papers in training set
Top 2%
0.7%
26
PLOS Digital Health
91 papers in training set
Top 3%
0.7%
27
Nature Biotechnology
147 papers in training set
Top 7%
0.7%
28
BMC Medical Research Methodology
43 papers in training set
Top 1%
0.7%
29
Computers in Biology and Medicine
120 papers in training set
Top 5%
0.7%
30
Physics in Medicine & Biology
17 papers in training set
Top 0.5%
0.7%